FRX and CYPB Said Phase III Milnacipran did not achieve statistical significance

September 28, 2005 5:02 PM EDT Send to a Friend
Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that preliminary top-line results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login